SHAANXI KANGHUI PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.94 CNY | +0.65% |
|
+10.90% | -25.73% |
| Apr. 26 | Shaanxi Kanghui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 15 | Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHAANXI KANGHUI PHARMACEUTICAL CO., LTD. is principally engaged in research and development, manufacture and sales of Chinese patent medicines. The Company's main products include Kun Fu Kang capsules (tablets), Fufang Shuanghua tablets, Xiaoyin granules, Fuguigutong capsules, Zhiyao Xiaoke capsules and Fufang Qingdai perfusates. The Company distributes its products just within China domestic market.
Sector
Pharmaceuticals
Calendar
2024-05-20
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -25.73% | 192M | |
| +20.61% | 43.18B | |
| +20.67% | 22.59B | |
| +14.56% | 14.56B | |
| +13.94% | 13.54B | |
| +43.35% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B |
- Stock Market
- Equities
- 603139 Stock
- News Shaanxi Kanghui Pharmaceutical Co., Ltd.
- Kanghui Pharma Sanctioned Over Failure to Disclose M&A Deal
